Mountain View-based
Complete Genomics, a provide of gene sequencing services, has set a pricing range for its IPO. The firm, which is looking to list on the NASDAQ Global Market as GNOM, said it expects its public offering price to be between $12.00 and $14.00 per share. Complete Genomics is venture backed by Essex Woodlands Health Ventures, OrbiMed Advisors, Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners and Highland Capital Management.
posted on Tuesday, October 26, 2010
Related companies:
COMPLETE CARE MEDICAL INC
Related stories:
> Complete Genomics Acquired For $117.6M By Chinese Firm
> Complete Genomics Prices IPO
> Complete Genomics Raises $45M
> Complete Genomics Chops Staff, Looks For Buyer
> Ooma Sets IPO Pricing Range
silicontap.com Home